Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Phentolamine mesylate by Opus Genetics for Presbyopia: Likelihood of Approval
Phentolamine mesylate is under clinical development by Opus Genetics and currently in Phase III for Presbyopia. According to GlobalData, Phase...